Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma
Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin
Pharma ASA at NOK 23.12 per share.

After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares,
corresponding to 2,33% ownership. Ferncliff Listed DAI AS are closely associated
with board member Øystein Stray Spetalen.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.